VOR
Vor Biopharma Inc. - Common Stock (VOR)
$88
About Vor Biopharma Inc. - Common Stock (VOR)
Vor Biopharma, Inc. is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. It is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.
Details
Daily high
$20.00
Daily low
$18.62
Price at open
$19.10
52 Week High
$26.00
52 Week Low
$6.50
Market cap
1.2B
Dividend yield
-
Volume
555,466
Avg. volume
753,963
P/E ratio
.54
Vor Biopharma Inc. - Common Stock News
Details
Daily high
$20.00
Daily low
$18.62
Price at open
$19.10
52 Week High
$26.00
52 Week Low
$6.50
Market cap
1.2B
Dividend yield
-
Volume
555,466
Avg. volume
753,963
P/E ratio
.54